Advertisement
GNW vs MET
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNW is a Hold and MET is a StrongBuy.
GNW's Stochastic Oscillator stays in oversold zone for 1 day
Be on the lookout for a price bounce soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GNW's RSI Indicator exited the oversold zone, 17 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for GNW just turned positive on October 28, 2026. Looking at past instances where GNW's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
Following a +2.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNW advanced for three days, in 208 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNW as a result. In 49 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
GNW broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GNW entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GNW's P/B Ratio (0.377) is slightly lower than the industry average of (1.337). P/E Ratio (16.415) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (0.463). Dividend Yield (0.046) settles around the average of (0.047) among similar stocks. P/S Ratio (0.562) is also within normal values, averaging (1.303).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. GNW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET in upward trend: 10-day moving average broke above 50-day moving average on October 13, 2026
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 55 cases where MET's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MET as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 10, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 33 of 53 cases over the following month. The odds of a continued upward trend are 62%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in 229 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Bearish Trend Analysis
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 20 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 23 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.276) is slightly higher than the industry average of (1.337). P/E Ratio (18.683) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GNW | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 14 | 19 | |
SMR RATING 1..100 | 93 | 99 | |
PRICE GROWTH RATING 1..100 | 60 | 23 | |
P/E GROWTH RATING 1..100 | 54 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GNW's Valuation (34) in the Life Or Health Insurance industry is in the same range as MET (55). This means that GNW’s stock grew similarly to MET’s over the last 12 months.
GNW's Profit vs Risk Rating (14) in the Life Or Health Insurance industry is in the same range as MET (19). This means that GNW’s stock grew similarly to MET’s over the last 12 months.
GNW's SMR Rating (93) in the Life Or Health Insurance industry is in the same range as MET (99). This means that GNW’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (23) in the Life Or Health Insurance industry is somewhat better than the same rating for GNW (60). This means that MET’s stock grew somewhat faster than GNW’s over the last 12 months.
MET's P/E Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for GNW (54). This means that MET’s stock grew somewhat faster than GNW’s over the last 12 months.
| GNW | MET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | 2 days ago 43% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 62% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 49% | 2 days ago 54% |
| Advances ODDS (%) | 8 days ago 66% | 2 days ago 66% |
| Declines ODDS (%) | 6 days ago 58% | 6 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 44% |
| Aroon ODDS (%) | 2 days ago 39% | 2 days ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GNW’s FA Score shows that 1 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
- GNW’s FA Score: 1 green, 4 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GNW’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 7 bullish TA indicator(s).
- GNW’s TA Score: 4 bullish, 4 bearish.
- MET’s TA Score: 7 bullish, 3 bearish.
Price Growth
GNW (@Life/Health Insurance) experienced а -3.77% price change this week, while MET (@Life/Health Insurance) price change was +1.76% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.54%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was -0.73%.
Reported Earning Dates
GNW is expected to report earnings on Feb 24, 2027.
MET is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Life/Health Insurance (+0.54% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.